Universal Beteiligungs und Servicegesellschaft mbH Lowers Stock Position in Stryker Corporation $SYK

Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of Stryker Corporation (NYSE:SYK) by 6.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 422,824 shares of the medical technology company’s stock after selling 30,390 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.11% of Stryker worth $167,282,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Mid American Wealth Advisory Group Inc. purchased a new position in Stryker in the second quarter worth $26,000. Sachetta LLC grew its stake in shares of Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 27 shares during the period. Ridgewood Investments LLC increased its holdings in shares of Stryker by 48.4% in the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares in the last quarter. Ransom Advisory Ltd acquired a new stake in shares of Stryker in the first quarter valued at about $37,000. Finally, MTM Investment Management LLC acquired a new stake in shares of Stryker in the second quarter valued at about $38,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 276,173 shares of the business’s stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $353.28, for a total value of $97,566,397.44. Following the completion of the transaction, the director directly owned 2,702,108 shares in the company, valued at approximately $954,600,714.24. The trade was a 9.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Viju Menon sold 500 shares of the firm’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the sale, the insider owned 12,511 shares in the company, valued at $4,886,921.71. This trade represents a 3.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 520,500 shares of company stock valued at $184,803,065. Company insiders own 5.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on SYK. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a report on Thursday. Rothschild Redb upgraded Stryker to a “hold” rating in a report on Thursday, September 18th. Truist Financial lifted their price objective on Stryker from $392.00 to $400.00 and gave the stock a “hold” rating in a report on Friday. Wells Fargo & Company boosted their target price on Stryker from $452.00 to $456.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $435.00 price target on shares of Stryker in a research report on Friday. Thirteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $434.37.

Stryker Stock Performance

NYSE SYK opened at $362.39 on Friday. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The business has a fifty day moving average of $371.96 and a 200-day moving average of $381.22. The stock has a market cap of $138.59 billion, a price-to-earnings ratio of 48.00, a price-to-earnings-growth ratio of 2.66 and a beta of 0.94.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 EPS for the quarter, topping analysts’ consensus estimates of $3.13 by $0.06. The firm had revenue of $6.06 billion during the quarter, compared to analysts’ expectations of $6.04 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter last year, the business posted $2.87 EPS. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. As a group, analysts predict that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.